Roche
ROG.SW
$274.16
Share price
0.30%
Change (1 day)
-17.36%
Change (1 year)
Categories
Operating Margin for Roche (ROG.SW)
Operating Margin at the end of 2022: 25.80%
According to Roche's latest financial reports and stock price the company's current Operating Margin is 25.80%. At the end of 2022 the company had an Operating Margin of 25.80%.
Operating Margin history for Roche from 2001 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | 25.80% | -6.87% |
| 2021 | 27.70% | -10.06% |
| 2020 | 30.80% | 13.96% |
| 2019 | 27.03% | 8.6% |
| 2018 | 24.89% | 8.31% |
| 2017 | 22.98% | -10.65% |
| 2016 | 25.72% | 3.29% |
| 2015 | 24.90% | -5.58% |
| 2014 | 26.37% | -15.96% |
| 2013 | 31.37% | 15.84% |
| 2012 | 27.08% | -3.08% |
| 2011 | 27.94% | 18.33% |
| 2010 | 23.62% | 13.21% |
| 2009 | 20.86% | -32.8% |
| 2008 | 31.04% | -6.42% |
| 2007 | 33.17% | 10.8% |
| 2006 | 29.94% | 18.58% |
| 2005 | 25.25% | -16.75% |
| 2004 | 30.33% | 94% |
| 2003 | 15.63% | -245.5% |
| 2002 | -10.75% | -165.8% |
| 2001 | 16.33% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 22.88% | -11.32% | 🇺🇸 USA |
 Novartis NVS | 17.27% | -33.06% | 🇨🇭 Switzerland |
 Pfizer PFE | 34.61% | 34.15% | 🇺🇸 USA |
 Abbott Laboratories ABT | 15.60% | -39.53% | 🇺🇸 USA |
 Amgen AMGN | 34.59% | 34.07% | 🇺🇸 USA |
 Sanofi SNY | 18.21% | -29.42% | 🇫🇷 France |
 Becton Dickinson BDX | 9.46% | -63.33% | 🇺🇸 USA |
 Merck MRK | 27.73% | 7.48% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 22.54% | -12.64% | 🇬🇧 UK |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.